RBC Capital Reiterates Outperform on Encompass Health, Maintains $83 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has reiterated his 'Outperform' rating on Encompass Health (NYSE:EHC) and maintained the price target at $83.
September 28, 2023 | 2:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Encompass Health's stock rating has been reiterated as 'Outperform' by RBC Capital, with a maintained price target of $83.
The reiteration of the 'Outperform' rating and the maintenance of the price target by a reputable analyst like Ben Hendrix from RBC Capital is a positive signal for Encompass Health. This could potentially lead to an increase in investor confidence and a positive impact on the stock's short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100